Search hospitals
>
Texas
>
Dallas
UT Southwestern/Simmons Cancer Center-Dallas
Claim this profile
Dallas, Texas 75390
Global Leader in Brain Tumor
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
688 reported clinical trials
69 medical researchers
Summary
UT Southwestern/Simmons Cancer Center-Dallas is a medical facility located in Dallas, Texas. This center is recognized for care of Brain Tumor, Cancer, Lung Cancer, Leukemia, Lymphoma and other specialties. UT Southwestern/Simmons Cancer Center-Dallas is involved with conducting 688 clinical trials across 639 conditions. There are 69 research doctors associated with this hospital, such as Martha M. Pacheco, David Miller, MD, Matthew Campbell, MD, and Syed M. Kazmi.
Area of expertise
Brain Tumor
UT Southwestern/Simmons Cancer Center-Dallas has run 84 trials for Brain Tumor. Some of their research focus areas include:
Cancer
UT Southwestern/Simmons Cancer Center-Dallas has run 84 trials for Cancer. Some of their research focus areas include:
Top PIs
Martha M. Pacheco
Saint Luke's Cancer Institute - Boise
8 years of reported clinical research
David Miller, MD
Parkland Memorial Hospital
3 years of reported clinical research
Matthew Campbell, MD
UT Southwestern/Simmons Cancer Center-Dallas
3 years of reported clinical research
Syed M. Kazmi
UT Southwestern/Simmons Cancer Center-Dallas
8 years of reported clinical research
Clinical Trials running at UT Southwestern/Simmons Cancer Center-Dallas
Lung Cancer
Bladder Cancer
Kidney Cancer
Prostate Cancer
Skin Cancer
Bladder Carcinoma
Brain Tumor
Uterine Cancer
Cancer
Esophageal cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting
2 awards
Phase 3
7 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UT Southwestern/Simmons Cancer Center-Dallas?
UT Southwestern/Simmons Cancer Center-Dallas is a medical facility located in Dallas, Texas. This center is recognized for care of Brain Tumor, Cancer, Lung Cancer, Leukemia, Lymphoma and other specialties. UT Southwestern/Simmons Cancer Center-Dallas is involved with conducting 688 clinical trials across 639 conditions. There are 69 research doctors associated with this hospital, such as Martha M. Pacheco, David Miller, MD, Matthew Campbell, MD, and Syed M. Kazmi.
Where is UT Southwestern/Simmons Cancer Center-Dallas located?
The UT Southwestern/Simmons Cancer Center-Dallas is located at 2201 Inwood Rd, Dallas, TX 75390, USA. For detailed directions, please call 214-648-6264.
Who should I call to ask about financial aid or insurance network?
**UT Southwestern/Simmons Cancer Center-Dallas Financial and Insurance Information** - **Billing and Insurance**: For inquiries, call 469-291-2000 or 866-648-2455. Secure messaging is available via MyChart under the Billing and Inquiries tab, selecting Billing Account Summary. In-person assistance is provided at Clements University Hospital, 6201 Harry Hines Blvd., Dallas, TX 75235, from 7:30 a.m. to 4:00 p.m. - **Financial Assistance**: Application forms are available in English and Spanish on the UT Southwestern Medical Center website or in person at the William P. Clements Jr. University Hospital Admission Office. For assistance, call 469-291-2000 or 866-648-2455. Submit applications to FinancialAssistance@ UT Southwestern Medical Center, P.O. Box 36423, Dallas, Texas 75235-9662. - **Financial Aid (Education)**: Contact the Office of Student Financial Aid at 214-648-3611 or via email at financialaid@utsouthwestern.edu. The office is located at M2.200 on South Campus, adjacent to Bryan Williams, M.D. Student Center.
What insurance does UT Southwestern/Simmons Cancer Center-Dallas accept?
UT Southwestern Medical Center, including Simmons Cancer Center-Dallas, accepts most major insurance plans. Not all UT Southwestern faculty providers participate in all plans, so it's recommended to contact the specific clinical practice or hospital to verify acceptance of your plan. For specific information on insurance plans accepted by Simmons Cancer Center-Dallas, contact them directly or visit their website.
What awards or recognition has UT Southwestern/Simmons Cancer Center-Dallas received?
UT Southwestern/Simmons Cancer Center-Dallas, located in Dallas, Texas, is a leading institution in cancer research and care, supported by grants from prestigious organizations including the National Cancer Institute (NCI), Alex’s Lemonade Stand Foundation (ALSF), American Cancer Society (ACS), and the Cancer Prevention Research Institute of Texas (CPRIT). These funds facilitate critical initiatives in breast cancer research, lung cancer screening, tobacco cessation programs, and the advancement of diagnostic and treatment methods through artificial intelligence and digital pathology. Notably, the center has been awarded nearly $19 million in CPRIT funding in 2024 and nearly $15 million in 2023 for its groundbreaking cancer research projects.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.